Evicenter
MarkdownMedical informationP&T meetings
VK2735

Chronic weight management

Last updated
184 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatment

Heterogeneity of treatment effect

11 evidence topics · 10 sources

Subcutaneous formulation: BMI category change by baseline obesity class in VENTURE
Baseline BMI categoryVK2735 participants (n)Placebo participants (n)VK2735: no change in obesity classPlacebo: no change in obesity class
Class III obesity“n=35”“n=15”“31 %”“87 %”
Class II obesity“n=51”“n=10”“18 %”“80 %”
Class I obesity“n=46”“n=8”“26 %”“75%”